MedTrace Logo

The Natural History of Procalcitonin in Hemorrhagic Stroke

NCT01498705 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-02-04

No results posted yet for this study

Summary

Approximately 12% of strokes in the United States are hemorrhagic.1 Hemorrhagic stroke can lead to multiple complications including fever that is not infectious. Identifying the cause of fever can help physicians choose the best care for the patient to try and prevent further damage to the already injured brain. Bacterial infection is one possible cause of fever in the stroke patient; however an incorrect diagnosis of infection can lead to unnecessary antibiotic use. Better screening tools for infection are being developed to help fight the problem of antibiotic resistance and unnecessary antibiotic use. Unnecessary use of antibiotics in patients increases the risk of adverse events and overall healthcare costs. Procalcitonin (PCT) is one such screening tool which has been used previously to help tell apart bacterial and nonbacterial causes of infection in other disease states; however, PCT has not been studied in hemorrhagic stroke patients. The purpose of this study is to understand the progress of PCT in hemorrhagic stroke patients in order to see whether PCT can be a useful marker for infection in these patients.

Conditions

  • Intraventricular Hemorrhage
  • Intracerebral Hemorrhage

Interventions

OTHER

Procalcitonin level

PCT level upon admission and on days 1, 3, and 5 following baseline level

Sponsors & Collaborators

  • CAMC Health System

    lead OTHER

Principal Investigators

  • Douglas W Haden, MD · WVU School of Medicine/Charleston Division

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-06-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01498705 on ClinicalTrials.gov